LUPIN.BO

LUPIN LTD. · Healthcare · Drug Manufacturers - Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$10.82B

PE Ratio

15.77

EV to Ebitda

—

Earnings Yield

6.00%

Revenue (TTM)

$2.58B

Net Income (TTM)

$686.0M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

24.00%

Profit Margin

17.00%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

—

All fundamentals

Core6 fields›

Market Cap$10.82B

Revenue TTM$2.58B

Shares Outstanding457.0M

Float240858861

Insider Ownership47.00%

Institutional Ownership32.00%

Growth Estimates5 fields›

Revenue Growth (Quarterly YoY)24.00%

Rev Growth Est 1Y Forward0.04

EPS Growth (Quarterly YoY)73.00%

EPS Growth Est Quarterly27.75

LT EPS Growth Estimates-8.00%

Operations16 fields›

Revenue TTM$2.58B

Gross Margin TTM70.00%

Gross Margin (Quarterly)74.00%

Operating Margin TTM26.00%

Operating Margin (Quarterly)21.00%

Operating Expenses TTM$37.8M

Profit Margin TTM17.00%

Profit Margin (Quarterly)16.00%

Net Income TTM$686.0M

EPS TTM94.37

EPS (Quarterly)25.72

EBITDA Margin TTM25.00%

EBITDA TTM$632.6M

Capex % of Revenue TTM9.00%

Capital Expenditures$234.9M

FCF % of Revenue (Quarterly)5.00%

Efficiency1 fields›

ROA11.00%

Valuation8 fields›

P/E (TTM)15.77

P/E Forward28.01

PEG0.85

EV/Revenues (TTM)3.98

Price To Book5.29

Price to Tangible Book7.1

Earnings Yield6.00%

Payout Ratio14.00%

Liquidity9 fields›

Cash Per Share65.49

Current Ratio1.87

Cash & ST Assets$30.40B

Goodwill & Intangibles$49967.70T

Total Assets$3.49B

Total Liabilities$4.60B

Shareholders Equity$2.04B

Interest Expense$37.8M

Goodwill % of Assets14915535.00%

Yields3 fields›

Payout Ratio14.00%

Earnings Yield6.00%

Buyback Yield0.00%